Our News

Our News

Find out about the latest events and advancements. This summarizes our press releases and latest events information.

2022

New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment

New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids

Benaroya Research Institute Awarded $11.4 M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes

Benaroya Research Institute Team Examines COVID Vaccine Response in People Under Treatment for MS and Other Autoimmune Diseases

Soo Jung Yang, PhD, Named Associate Member in the Center for Translational Research at Benaroya Research Institute

BRI Research Team Links Down Syndrome, Aging and Autoimmunity

2021

Benaroya Research Institute at Virginia Mason Receives Second 7-Year Award from the National Institutes of Health to Lead the Immune Tolerance Network

What COVID-19 is Teaching Us About the Immune System

2020

Early introduction of gluten may prevent celiac disease in children

Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses

GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases

Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason

Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason

Dr. Harrison Awarded First NOSTER Science Microbiome Prize

COVID-19 Research Continues

Pages